<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31375896</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion.</ArticleTitle><Pagination><StartPage>667</StartPage><EndPage>670</EndPage><MedlinePgn>667-670</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-019-02050-8</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cykowski</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-5973-803X</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Genomic Medicine, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA. mdcykowski@houstonmethodist.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Academic Medicine at the Houston Methodist Research Institute, Houston Methodist Hospital, 6565 Fannin St, Houston, TX, 77030, USA. mdcykowski@houstonmethodist.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickson</LastName><ForeName>Dennis W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Suzanne Z</ForeName><Initials>SZ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Genomic Medicine, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Academic Medicine at the Houston Methodist Research Institute, Houston Methodist Hospital, 6565 Fannin St, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist Neurological Institute, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arumanayagam</LastName><ForeName>Anithachristy S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Genomic Medicine, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Andreana L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Pathology and Genomic Medicine, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Academic Medicine at the Houston Methodist Research Institute, Houston Methodist Hospital, 6565 Fannin St, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist Neurological Institute, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appel</LastName><ForeName>Stanley H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Institute of Academic Medicine at the Houston Methodist Research Institute, Houston Methodist Hospital, 6565 Fannin St, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist Neurological Institute, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley H. Appel Department of Neurology, Houston Methodist Hospital, 6565 Fannin St., Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31375896</ArticleId><ArticleId IdType="pmc">PMC6778061</ArticleId><ArticleId IdType="doi">10.1007/s00401-019-02050-8</ArticleId><ArticleId IdType="pii">10.1007/s00401-019-02050-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Powell SZ, Appel JW, Arumanayagam AS, Rivera AL, Appel SH. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2018;6:28. doi: 10.1186/s40478-018-0528-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pmc">PMC5899326</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert AR, Chevez-Barrios P, Cykowski MD. Perineurial-like cells and EMA expression in the suprachoroidal region of the human eye. J Histochem Cytochem. 2018;66:367&#x2013;375. doi: 10.1369/0022155418756308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155418756308</ArticleId><ArticleId IdType="pmc">PMC5958356</ArticleId><ArticleId IdType="pubmed">29446690</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Deza J, Lee YB, Troakes C, Nolan M, Al-Sarraj S, Gallo JM, et al. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol Commun. 2015;3:38. doi: 10.1186/s40478-015-0218-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0218-y</ArticleId><ArticleId IdType="pmc">PMC4479315</ArticleId><ArticleId IdType="pubmed">26108573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, et al. Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Grasser FA, Gendron TF, Petrucelli L, Cashman NR, et al. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015;130:845&#x2013;861. doi: 10.1007/s00401-015-1476-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH. Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Grasser FA, Rentzsch K, Kremmer E, Kupper C, et al. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 2015;130:537&#x2013;555. doi: 10.1007/s00401-015-1450-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw MP, Higginbottom A, McGown A, Castelli LM, James E, Hautbergue GM, et al. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathol Commun. 2018;6:125. doi: 10.1186/s40478-018-0629-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0629-7</ArticleId><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>Swartz EW, Baek J, Pribadi M, Wojta KJ, Almeida S, Karydas A, et al. A novel protocol for directed differentiation of C9orf72-associated human induced pluripotent stem cells into contractile skeletal myotubes. Stem Cells Transl Med. 2016;5:1461&#x2013;1472. doi: 10.5966/sctm.2015-0340.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2015-0340</ArticleId><ArticleId IdType="pmc">PMC5070503</ArticleId><ArticleId IdType="pubmed">27369896</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Bento-Abreu A, Gendron TF, Boeynaems S, Bogaert E, Nuyts R, et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk M, Haaker G, Winter L, Just W, Nickel FT, Linker RA, et al. C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle. Muscle Nerve. 2014;50:454&#x2013;455. doi: 10.1002/mus.24283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24283</ArticleId><ArticleId IdType="pubmed">24817207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>